Vir Biotechnology, Inc. · BX:VIR
Vir Biotechnology, Inc. shareholders
As of Sep 30, 2026, 257 institutions reported holding Vir Biotechnology, Inc., 81.8% of its shares. Largest: BlackRock, Vanguard and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|---|
| BlackRock | 22.4M | 13.1% | US$251M | +1.77M | Nov 13, 2026 |
| Vanguard | 19.6M | 11.4% | US$219M | +655K | Nov 16, 2026 |
| ARCH Venture Management, LLC | 12.7M | 7.4% | US$142M | No change | Nov 16, 2026 |
| Sb Investment Advisers (UK) LTD | 10.9M | 6.4% | US$122M | No change | Nov 17, 2026 |
| GSK plc | 8.55M | 5.0% | US$95.6M | No change | Nov 5, 2026 |
| State Street | 7.82M | 4.6% | US$87.5M | −2.14M | Nov 12, 2026 |
| Point72 Asset Management, L.P. | 6.77M | 4.0% | US$75.7M | +1.11M | Nov 16, 2026 |
| Dimensional | 3.32M | 1.9% | US$37.1M | +198K | Nov 4, 2026 |
| Geode Capital | 3.02M | 1.8% | US$33.8M | −329K | Nov 6, 2026 |
| Mpm Bioimpact LLC | 2.81M | 1.6% | US$31.4M | New | Nov 16, 2026 |
| Nuveen | 2.22M | 1.3% | US$24.8M | +239K | Nov 10, 2026 |
| ADAR1 Capital Management, LLC | 2.16M | 1.3% | US$24.1M | −298K | Nov 16, 2026 |
| Saturn V Capital Management LP | 2.04M | 1.2% | US$22.8M | +1.27M | Nov 16, 2026 |
| Pictet Asset Management Holding SA | 1.9M | 1.1% | US$21.3M | −48,558 | Nov 3, 2026 |
| Morgan Stanley | 1.77M | 1.0% | US$19.8M | −441K | Nov 13, 2026 |
| Northern Trust | 1.48M | 0.87% | US$16.6M | +50,099 | Nov 16, 2026 |
| Schwab | 1.46M | 0.85% | US$16.3M | +133K | Nov 16, 2026 |
| Hudson Bay Capital Management LP | 1.18M | 0.69% | US$13.1M | −189K | Nov 13, 2026 |
| Two Sigma | 1.13M | 0.66% | US$12.7M | +23,057 | Nov 16, 2026 |
| Bank of America | 1.03M | 0.60% | US$11.6M | −109K | Nov 16, 2026 |
| Sio Capital Management, LLC | 873K | 0.51% | US$9.76M | −202K | Nov 16, 2026 |
| Goldman Sachs | 847K | 0.49% | US$9.47M | −1.52M | Nov 16, 2026 |
| Savvy Advisors, Inc. | 838K | 0.49% | US$9.36M | −203K | Nov 12, 2026 |
| JPMorgan | 834K | 0.49% | US$8.89M | +31,745 | Nov 12, 2026 |
| GordonMD Global Investments LP | 804K | 0.47% | US$8.98M | −550K | Nov 16, 2026 |
| BNY | 732K | 0.43% | US$8.18M | +37,220 | Nov 5, 2026 |
| Fidelity | 640K | 0.37% | US$7.16M | −1.68M | Nov 10, 2026 |
| BNP Paribas | 640K | 0.37% | US$7.15M | −15,430 | Nov 12, 2026 |
| Candriam S.C.A. | 616K | 0.36% | US$6.91M | −11,011 | Nov 3, 2026 |
| Clearstead Advisors, LLC | 608K | 0.36% | US$6.8M | −33 | Nov 6, 2026 |
| Principal | 607K | 0.35% | US$6.79M | +20,127 | Nov 2, 2026 |
| Superstring Capital Management LP | 579K | 0.34% | US$6.47M | −275K | Nov 16, 2026 |
| Susquehanna | 564K | 0.33% | US$6.31M | +182K | Nov 16, 2026 |
| Nordea Investment Management AB | 546K | 0.32% | US$5.97M | −47,599 | Nov 9, 2026 |
| Invesco | 539K | 0.31% | US$6.03M | +63,416 | Nov 12, 2026 |
| Alta Partners Management Company, L.P. | 518K | 0.30% | US$5.79M | +8,000 | Nov 16, 2026 |
| Parkman Healthcare Partners LLC | 517K | 0.30% | US$5.78M | +42,098 | Nov 16, 2026 |
| Nomura | 500K | 0.29% | US$5.59M | New | Nov 16, 2026 |
| UBS | 445K | 0.26% | US$4.97M | −181K | Nov 16, 2026 |
| Public Sector Pension Investment Board | 432K | 0.25% | US$4.65M | +14,520 | Nov 10, 2026 |
| American Century | 409K | 0.24% | US$4.57M | +60,126 | Nov 20, 2026 |
| Citadel | 403K | 0.24% | US$4.5M | −589K | Nov 16, 2026 |
| Renaissance Technologies | 396K | 0.23% | US$4.43M | −621K | Nov 12, 2026 |
| Ensign Peak Advisors, Inc | 390K | 0.23% | US$4.36M | −444K | Nov 12, 2026 |
| Panagora Asset Management Inc | 371K | 0.22% | US$4.15M | −3,356 | Nov 12, 2026 |
| AQR Capital Management LLC | 352K | 0.21% | US$3.94M | −229K | Nov 16, 2026 |
| Edgestream Partners, L.P. | 340K | 0.20% | US$3.8M | +206K | Nov 9, 2026 |
| Hrt Financial LP | 334K | 0.20% | US$3.73M | +26,038 | Nov 13, 2026 |
| Rhumbline Advisers | 295K | 0.17% | US$3.3M | +9,730 | Nov 10, 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 276K | 0.16% | US$3.08M | +79,211 | Nov 16, 2026 |
This page holds 50 of 257 holders.
Funds
| Holder | Shares | Of the company | Value | Change | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.32M | 4.3% | US$74.6M | +547K | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 4.95M | 2.9% | US$50.4M | +2.42M | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 4.85M | 2.8% | US$49.4M | +871K | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 3.48M | 2.0% | US$35.4M | +574K | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3.16M | 1.8% | US$32.2M | +878K | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2M | 1.2% | US$20.3M | +373K | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 1.76M | 1.0% | US$18M | +467K | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1.4M | 0.82% | US$14.3M | +133K | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1.34M | 0.78% | US$11.6M | +420K | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 1.15M | 0.67% | US$11.7M | +350K | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 1.11M | 0.65% | US$11.4M | +77,651 | Jun 30, 2026 |
| iShares Biotechnology ETF | 949K | 0.55% | US$9.67M | +245K | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 892K | 0.52% | US$7.73M | −17,660 | Jul 31, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 869K | 0.51% | US$8.85M | +396K | Jun 30, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 677K | 0.40% | US$6.9M | No change | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 655K | 0.38% | US$5.67M | +2,449 | Jul 31, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 621K | 0.36% | US$6.33M | −29,144 | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 586K | 0.34% | US$5.59M | −1,623 | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 539K | 0.31% | US$5.15M | +39,519 | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 536K | 0.31% | US$4.64M | +8,129 | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 519K | 0.30% | US$4.5M | +3,627 | Jul 31, 2026 |
| Nomura Healthcare Fund | 500K | 0.29% | US$5.09M | No change | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 479K | 0.28% | US$4.57M | +37,010 | May 31, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 449K | 0.26% | US$4.58M | +47,419 | Jun 30, 2026 |
| JPMorgan Small & Mid Cap Enhanced Equity ETF | 424K | 0.25% | US$4.32M | +16,831 | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 414K | 0.24% | US$4.22M | New | Jun 30, 2026 |
| Vanguard Explorer Fund | 410K | 0.24% | US$3.55M | No change | Jul 31, 2026 |
| Nuveen Quant Small/Mid Cap Equity Fund | 394K | 0.23% | US$3.42M | No change | Jul 31, 2026 |
| Vanguard S&P Small-Cap 600 Index Fund | 390K | 0.23% | US$3.72M | +64,832 | May 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 373K | 0.22% | US$3.23M | +165K | Jul 31, 2026 |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF | 368K | 0.21% | US$3.75M | +7,415 | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 364K | 0.21% | US$3.47M | −4,512 | May 29, 2026 |
| Vanguard Health Care Index Fund | 351K | 0.21% | US$3.35M | +33,665 | May 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 349K | 0.20% | US$3.56M | +301K | Jun 30, 2026 |
| Vanguard Market Neutral Fund | 348K | 0.20% | US$3.55M | +97,762 | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 299K | 0.17% | US$2.59M | +93,575 | Jul 31, 2026 |
| iShares Genomics Immunology and Healthcare ETF | 289K | 0.17% | US$2.51M | +122K | Jul 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 283K | 0.17% | US$2.7M | +40,701 | May 31, 2026 |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | 276K | 0.16% | US$2.82M | −243K | Jun 30, 2026 |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF | 271K | 0.16% | US$2.76M | +26,659 | Jun 30, 2026 |
| Master Small Cap Index Series | 230K | 0.13% | US$2.34M | +81,243 | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 211K | 0.12% | US$2.01M | +26,049 | May 31, 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 209K | 0.12% | US$1.81M | +413 | Jul 31, 2026 |
| JNL Small Cap Index Fund | 190K | 0.11% | US$1.93M | +16,577 | Jun 30, 2026 |
| U.S. Core Equity 2 Portfolio | 187K | 0.11% | US$1.62M | No change | Jul 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 172K | 0.10% | US$1.76M | +4,080 | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 172K | 0.10% | US$1.64M | +32,597 | May 31, 2026 |
| Fidelity Small Cap Value Index Fund | 172K | 0.10% | US$1.75M | +56,170 | Jun 30, 2026 |
| Columbia Small Cap Index Fund | 168K | 0.10% | US$1.61M | +17,911 | May 31, 2026 |
| Direxion Daily S&P Biotech Bull 3X Shares | 168K | 0.10% | US$1.46M | +23,373 | Jul 31, 2026 |
This page holds 50 of 239 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| BlackRock, Inc. | 12.40% | 20.9M | Sep 30, 2026 |
| Robert Nelsen | 7.30% | 12.5M | Nov 4, 2026 |
| Vanguard Portfolio Management LLC | 6.85% | 11.6M | Jun 30, 2026 |
| Sb Investment Advisers (UK) LTD | 6.50% | 10.9M | Mar 31, 2026 |